DNA X Inc.
Last updated September 27, 2026
Organization details
- Legal name
- DNA X Inc.
- Former names
- Sonim Technologies Inc
- Ownership
- Public
- Status
- Active
- SIC code
- 3661 — Telephone & Telegraph Apparatus
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- SAN Diego
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- SONM
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001178697
- EIN
- 94-3336783
Board of directors
-
Alan B. Howe · DirectorSince 2023
-
George Thangadurai · DirectorSince 2025
-
Hao Peter Liu · Director · Chief Executive OfficerSince 2023
-
Jack Steenstra · DirectorSince 2023
-
James S. Cassano · DirectorSince 2023
-
Jeffrey Wang · DirectorSince 2023
-
Michael C. Mulica · Director · Acting CEOSince 2023
Chief executives
Hao Peter Liu
· Chief Executive Officer
Dates unknown
Dates unknown
Director election results
Annual meeting of July 17, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
56.4%
-
85.9%
-
85.9%
-
90.0%
Board connections
2 of this board's directors also sit on 4 other boards.
- via Alan B. Howe
- via Alan B. Howe
- via Michael C. Mulica
- via Alan B. Howe
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 9, 2026 | Crolius Clayton Officer (Chief Financial Officer) | Grant or award | +35,000 | — | — |
| Feb 9, 2026 | Michael C. Mulica Director, Officer (Acting CEO) | Grant or award | +50,000 | — | — |
| Jun 30, 2025 | LYTTON LAURENCE W 10% owner | Open-market sale | −400,514 | $1.39 | $556,714 |
| Jun 26, 2025 | LYTTON LAURENCE W 10% owner | Open-market sale | −466,402 | $1.50 | $699,603 |
| Apr 23, 2025 | James S. Cassano Director | Open-market sale | −23,381 | $1.45 | $33,902 |
| Apr 23, 2025 | Michael C. Mulica Director | Open-market sale | −27,818 | $1.45 | $40,336 |
| Apr 23, 2025 | Jack Steenstra Director | Open-market sale | −23,381 | $1.45 | $33,902 |
| Apr 23, 2025 | Becher Charles Officer (See Remarks) | Open-market sale | −31,326 | $1.45 | $45,423 |
| Apr 23, 2025 | Jeffrey Wang Director | Open-market sale | −4,478 | $1.45 | $6,493 |
| Apr 23, 2025 | Crolius Clayton Officer (Chief Financial Officer) | Open-market sale | −11,634 | $1.45 | $16,869 |
| Mar 31, 2025 | Michael C. Mulica Director | Grant or award | +46,728 | — | — |
| Mar 31, 2025 | Jack Steenstra Director | Grant or award | +46,728 | — | — |
| Mar 31, 2025 | James S. Cassano Director | Grant or award | +46,728 | — | — |
| Feb 6, 2025 | Hao Peter Liu Director, Officer (Chief Executive Officer) | Grant or award | +63,604 | — | — |
| Feb 6, 2025 | Becher Charles Officer (See Remarks) | Grant or award | +70,671 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.